Skip to main content

ORIGINAL RESEARCH article

Front. Endocrinol.
Sec. Cancer Endocrinology
Volume 15 - 2024 | doi: 10.3389/fendo.2024.1351982
This article is part of the Research Topic Metabolic Abnormalities on the Incidence and Prognosis of Gynecological Malignant Tumors View all 5 articles

Association between metabolic disorders and clinicopathologic features in endometrial cancer

Provisionally accepted
YuanPei Wang YuanPei Wang Qianwen Liu Qianwen Liu Yi Sun Yi Sun Weijia Wu Weijia Wu Xiaoran Cheng Xiaoran Cheng Xuerou Chen Xuerou Chen Fang Ren Fang Ren *
  • Department of Gynecology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China

The final, formatted version of the article will be published soon.

    Background: In recent years, the incidence of Endometrial cancer (EC) has been on the rise due to high-fat, high-calorie diets and low-exercise lifestyles. However, the relationships between metabolic disorders and the progression of EC remain uncertain. The purpose of our study was to explore the potential association between obesity, hypertension, hyperglycemia and clinicopathologic characteristics in EC patients.In categorical variables, Chi-square tests were used to calculate P values. Univariate logistic regression and multivariate logistic regression were used to identify the risk factors of myometrial invasion>1/2 and lymph node metastasis. Overall survival (OS) was estimated using the Kaplan-Meier method.The study included 406 individuals with EC, 62.6% had type I and 37.4% had type II.Hypertension was seen in 132 (32.5%), hyperglycemia in 75 (18.5%), and overweight or obesity in clinicopathologic features of EC. Multivariate logistic regression revealed that hyperglycemia (OR=2.439,95% CI: 1.025-5.804, P = 0.044) was a risk factor for myometrial invasion depth >1/2 in patients with type I EC, and hypertension (OR=32.124,95% CI: 3.287-313.992, P = 0.003) was a risk factor for lymph node metastasis in patients with type I EC. Survival analysis found that hyperglycemia (P < 0.001) and hypertension (P = 0.002) were associated with OS in type I EC.Neither hyperglycemia, hypertension, nor obesity were associated with the prognosis in type II EC.Hyperglycemia was a risk factor for myometrial invasion depth >1/2 in patients with type I EC and hypertension was a risk factor for lymph node metastasis in patients with type I EC.Hypertension and hyperglycemia were associated with poor prognosis in patients with type I EC.

    Keywords: endometrial cancer, Hyperglycemia, Hypertension, Obesity, lymph node metastasis

    Received: 07 Dec 2023; Accepted: 09 Aug 2024.

    Copyright: © 2024 Wang, Liu, Sun, Wu, Cheng, Chen and Ren. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Fang Ren, Department of Gynecology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, Henan Province, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.